<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04554290</url>
  </required_header>
  <id_info>
    <org_study_id>2020PI061</org_study_id>
    <nct_id>NCT04554290</nct_id>
  </id_info>
  <brief_title>Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery Biopsy</brief_title>
  <official_title>Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery Biopsy: a Monocentric Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Temporal artery biopsy is a useful tool helping to the diagnosis of giant cell arteritis.&#xD;
      However, other diagnoses might be associated with abnormal temporal artery biopsy. The&#xD;
      purpose of this study is to describe the frequency of giant cell arteritis differential&#xD;
      diagnoses with positive temporal artery biopsy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of giant cell arteritis and differential diagnoses</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">114</enrollment>
  <condition>Giant Cell Arteritis</condition>
  <condition>Vasculitis</condition>
  <arm_group>
    <arm_group_label>positive temporal artery biopsy</arm_group_label>
    <description>all adult patients with significant inflammation shown on temporal artery biopsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>temporal artery biopsy</intervention_name>
    <description>description of temporal artery biopsy features, and its correlation with diagnosis of giant cell arteritis or other differential diagnoses.</description>
    <arm_group_label>positive temporal artery biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all patients with significant inflammation on temporal artery biospy, with a final&#xD;
        diagnosis of giant cell arteritis or an other diagnosis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  positive artery biopsy between january 1st 2000 and july 25th 2019&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  orther vascular biopsy than temporal artery biospy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Thomas Moulinet, MD</last_name>
    <phone>+33 3 83 15 53 04</phone>
    <email>t.moulinet@chru-nancy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nancy University Hospital</name>
      <address>
        <city>Nancy</city>
        <state>Lorraine</state>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moulinet</last_name>
      <phone>+33 3 83 15 53 04</phone>
      <email>t.moulinet@chru-nancy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 14, 2020</study_first_submitted>
  <study_first_submitted_qc>September 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2020</study_first_posted>
  <last_update_submitted>September 14, 2020</last_update_submitted>
  <last_update_submitted_qc>September 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>Thomas MOULINET</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>giant cell arteritis</keyword>
  <keyword>temporal artery biopsy</keyword>
  <keyword>vasculitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polymyalgia Rheumatica</mesh_term>
    <mesh_term>Giant Cell Arteritis</mesh_term>
    <mesh_term>Vasculitis</mesh_term>
    <mesh_term>Arteritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

